Proud to share the acceptance of my latest first-author publication, a significant step in my postdoctoral journey at @CedarsSinai Medical Center.
Our study, “Changing Landscape of Steatotic Liver Diseases and Liver Fibrosis in the United States During the COVID-19 Pandemic”
Honored to receive a Certificate of Reviewing from Gastroenterology ; One of the leading journals in our field, with an impact factor of 26.3 and ranked #1 in gastroenterology and hepatology on Google Scholar.
Grateful for the opportunity to contribute to the peer-review process.
🎉 Exciting News! Our latest meta-analysis & systematic review is published in Journal of Clinical Oncology!
📌 Title: Association between irAEs & prognosis after ICIs in HCC
🔗 Read more: https://t.co/87t9BDB2qG
#HCC#Oncology#CancerResearch#Immunotherapy#CheckpointInhibi
We are hiring a #postdoc and a research technician at @WeillCornell Medicine - Cornell University in New York City! We study the impact of diet and gut microbiota on inflammation, immunity, metabolism, and cancer. Join us if you are interested in #immunology and the #microbiota.
🎉 Thrilled to Announce a New Publication in Clinical Gastroenterology and Hepatology (IF: 11.6)! 📚✨
"Global Trend of MASH-associated Liver Cancer: A Systematic Analysis from the Global Burden of Disease 2021"
Access the full article here: https://t.co/FSCFCGaiSm
#Research
🌟 Excited to share our manuscript, "Increased MASH-associated Liver Cancer in Younger Demographics," is accepted in Hepatology Communications! 🎉
Grateful to our team & @Pojsakorn for the support.
🚀 Advancing hepatology research together!
#Hepatology#MASLD#MASH
🌟 Exciting News! 🌟
I’m thrilled to announce the publication of my first USA research paper as part of my new affiliation with Cedars-Sinai Medical Center!
Special thanks to my dear friend @PojsakornDan